Clavimox 125 mg/31.25 mg Syrup
By Clavimox
Rx
30ml Syrup in a Bottle

Composition
Amoxycillin(125mg) + Clavulanic Acid(31.25mg)

Manufacturer - Lark Laboratories Ltd
A-105/2, Okhla Industrial Area, Phase-II, New Delhi-110020

Expires on or after
September, 2025
About Clavimox 125 mg/31.25 mg Syrup
Clavimox 125 mg/31.25 mg Syrup is an antibiotic medication specifically designed to combat bacterial infections affecting various parts of the body. This syrup is effective in treating infections of the ear, nose, throat, chest, lungs, teeth, skin, and urinary tract. It is particularly valuable for tackling bacterial strains that have developed resistance to other antibiotics, including cases of tuberculosis that resist conventional treatments.
Administration of Clavimox 125 mg/31.25 mg Syrup to children can be done with or without food, although it is generally recommended to administer it with food. This practice can enhance absorption and reduce the likelihood of stomach irritation. The frequency of dosages usually ranges from two to three times a day, as determined by the doctor based on factors such as the severity of the infection, the specific type of infection, and the child's body weight and age. It is crucial to strictly adhere to the prescribed dosage, timing, and method of administration. In cases where the child vomits the syrup within 30 minutes of intake, the dose can be repeated after allowing the child to settle, without doubling up if the next dose is imminent.
Potential side effects of Clavimox 125 mg/31.25 mg Syrup may include vomiting, diarrhea, nausea, abdominal discomfort, dark urine, and allergic reactions. It is important to note that these side effects typically subside on their own. However, should they persist or significantly impact the child's well-being, immediate consultation with the child's doctor is necessary.
To ensure safe and effective usage of Clavimox 125 mg/31.25 mg Syrup, it is essential to disclose the child's complete medical history to the healthcare provider. This includes any prior incidents of allergies, heart conditions, blood disorders, birth defects, airway obstructions, lung abnormalities, digestive issues, skin conditions, liver complications, and kidney malfunctions. Such comprehensive information enables the doctor to make informed decisions regarding dosage adjustments and formulate an appropriate treatment plan for the child's overall well-being.
Benefits
Clavimox 125 mg/31.25 mg Syrup offers multiple benefits in treating various health conditions. Primarily, it is highly effective in combating resistant tuberculosis. In cases of multidrug-resistant tuberculosis, where bacteria develop resistance to antibiotics due to an enzyme called beta-lactamase, Clavimox 125 mg/31.25 mg Syrup comes to the rescue. The combination of amoxycillin and clavulanic acid in Clavimox 125 mg/31.25 mg Syrup works wonders here. While amoxycillin targets and eliminates the tuberculosis-causing bacteria, clavulanic acid prevents the beta-lactamase enzyme from rendering amoxycillin ineffective. This synergistic action ensures the successful treatment of resistant tuberculosis, making Clavimox 125 mg/31.25 mg Syrup a valuable option in such challenging cases.
Moreover, Clavimox 125 mg/31.25 mg Syrup is also beneficial in the treatment of various bacterial infections. The dual action of its components, amoxycillin and clavulanic acid, makes it a potent weapon against bacteria. Amoxycillin halts the growth of bacteria, while clavulanic acid enhances amoxycillin's activity and reduces resistance to the antibiotic. This combination therapy is effective in addressing infections in different parts of the body, including the ears, sinuses, throat, lungs, urinary tract, skin, teeth, joints, and bones. Patients often experience improvement within a few days of starting Clavimox 125 mg/31.25 mg Syrup, but it is crucial to complete the prescribed course to ensure all bacteria are eradicated and prevent the development of resistance.
In conclusion, Clavimox 125 mg/31.25 mg Syrup offers a comprehensive solution for treating both resistant tuberculosis and various bacterial infections. Its potency, efficacy, and ability to combat antibiotic resistance make it a valuable asset in the fight against these challenging health conditions.
How to use the Clavimox 125 mg/31.25 mg Syrup
To properly use Clavimox 125 mg/31.25 mg Syrup, it is essential to follow the instructions provided by your doctor. Before taking the medicine, carefully read the label for guidance. Use a measuring cup to ensure you are taking the correct dose and take it orally by mouth. Remember to shake the bottle well before each use. It is recommended to take Clavimox 125 mg/31.25 mg Syrup with food to help avoid any potential stomach discomfort. Following these steps will help you use the medication effectively and get the best results for your health.
Uses of Clavimox 125 mg/31.25 mg Syrup
Clavimox 125 mg/31.25 mg Syrup is commonly used in the treatment of resistant tuberculosis (TB) and bacterial infections. It is an effective medication for combating these conditions and is prescribed by healthcare professionals to help patients recover and heal. Resistant tuberculosis is a serious and challenging disease, and Clavimox 125 mg/31.25 mg Syrup is one of the medications used to fight against it. Bacterial infections, which can affect various parts of the body, also respond well to treatment with Clavimox 125 mg/31.25 mg Syrup. Patients prescribed with Clavimox 125 mg/31.25 mg Syrup should follow their healthcare provider's directions carefully to ensure the best possible outcome in fighting these infections.
What conditions Clavimox 125 mg/31.25 mg Syrup treats?
Clavimox 125 mg/31.25 mg Syrup is used to treat bacterial infections in various parts of the body like the ear, nose, throat, lungs, skin, teeth, and urinary tract. This medicine is effective against bacterial strains that are resistant to other treatments, including tuberculosis. The combination of amoxycillin and clavulanic acid in Clavimox 125 mg/31.25 mg Syrup helps combat multidrug-resistant tuberculosis by preventing the bacteria from becoming resistant to treatment. It works by stopping the growth of bacteria and enhancing the activity of amoxycillin to fight infections. Stick to prescribed dosages and consult the doctor if any side effects persist.
Should you consult a doctor?
If your child experiences persistent or bothersome side effects such as vomiting, diarrhea, nausea, abdominal pain, dark colored urine, or signs of an allergy while taking Clavimox 125 mg/31.25 mg Syrup, it is important to consult your child's doctor promptly. Additionally, if your child has a history of allergies, heart conditions, blood disorders, birth defects, lung or gastrointestinal issues, or any liver or kidney problems, it is crucial to inform the doctor before starting Clavimox 125 mg/31.25 mg Syrup. This will help the doctor make appropriate adjustments to the dosage and treatment plan. Remember to follow the prescribed dosage schedule and administration instructions provided by the doctor. If your child vomits within 30 minutes of taking the syrup, wait for the child to settle down and then administer the dose again, but do not give a double dose. It is recommended to give Clavimox 125 mg/31.25 mg Syrup with food to improve absorption and reduce the risk of stomach upset. Your child's safety and well-being are the top priority, so do not hesitate to reach out to the doctor if you have any concerns or questions regarding the medication.
Side effects of Clavimox 125 mg/31.25 mg Syrup
When taking Clavimox 125 mg/31.25 mg Syrup, most children do not experience serious side effects. However, if side effects do arise, they are usually temporary and tend to improve as the body adjusts to the medication. It is essential to consult your child's doctor if any side effects persist or if your child is particularly bothered by them. Some common side effects that may occur with Clavimox 125 mg/31.25 mg Syrup include abdominal pain, allergies, vomiting, nausea, diarrhea, mucocutaneous candidiasis, and dark-colored urine.
Safety advice

liver
When it comes to using Clavimox 125 mg/31.25 mg Syrup, caution is advised for patients with liver disease. It may be necessary to adjust the dosage of this syrup in such cases. It is important to consult your doctor before starting treatment with Clavimox 125 mg/31.25 mg Syrup if you have any liver issues. Additionally, if you are considering giving this syrup to your child and they have a severe form of liver disease, it is recommended to first consult with your child's doctor. Remember, always prioritize seeking professional medical advice when dealing with liver-related concerns and the use of Clavimox 125 mg/31.25 mg Syrup.

kidney
Clavimox 125 mg/31.25 mg Syrup requires caution in kidney disease, as dose adjustment may be necessary. Consult your doctor before use.
Consumption warning before consuming Clavimox 125 mg/31.25 mg Syrup
Before giving Clavimox 125 mg/31.25 mg Syrup to your child, it's important to note the following precautions. This antibiotic medication is effective against various bacterial infections in different parts of the body. It can be administered with or without food, preferably with food to enhance absorption and reduce the chances of stomach upset. The dosage, frequency, and administration method should strictly follow the doctor's instructions based on the infection severity, type, and your child's weight and age.
Possible side effects of Clavimox 125 mg/31.25 mg Syrup include vomiting, diarrhea, nausea, abdominal pain, dark urine, and allergic reactions. While these side effects typically subside on their own, persistent or severe symptoms should prompt immediate consultation with the child's doctor. Prior to starting treatment, provide a comprehensive medical history of your child, detailing any allergies, heart issues, blood disorders, birth defects, respiratory or gastrointestinal problems, skin conditions, liver or kidney impairment. This information aids in determining appropriate dosages and developing a tailored treatment plan.
What if you forgot to take Clavimox 125 mg/31.25 mg Syrup?
If you forget to give a dose of Clavimox 125 mg/31.25 mg Syrup to your child, you can still give it as soon as you remember, unless the doctor tells you otherwise. However, if it's almost time for the next scheduled dose, it's best to skip the missed dose altogether. It's important not to give a double dose to make up for the missed one. Make sure to follow the dosing schedule prescribed by the doctor to ensure the effectiveness of the medication.
Related lab tests
When taking Clavimox 125 mg/31.25 mg Syrup, it is important to monitor your health with related lab tests. These tests include: Complete Blood Count, which measures the number of red blood cells, white blood cells, and platelets in your blood; Erythrocyte Sedimentation Rate, which helps detect inflammation in the body; Mycobacterium Tuberculosis DNA PCR - a qualitative test used to diagnose tuberculosis; and Peripheral Smear Examination, which examines a sample of your blood under a microscope to look for abnormalities in blood cells. Regularly monitoring these lab tests can help ensure your health and the effectiveness of Clavimox 125 mg/31.25 mg Syrup treatment.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹61.62
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024